Accessibility Menu
 

Anbio Biotechnology

(NASDAQ) NNNN

Current Price$28.85
Market Cap$1.25B
Since IPO (2025)+395%
5 YearN/A
1 Year+354%
1 Month+39%

Anbio Biotechnology Financials at a Glance

Market Cap

$1.25B

Revenue (TTM)

$18.60M

Net Income (TTM)

$9.75M

EPS (TTM)

$0.16

P/E Ratio

174.34

Dividend

$0.00

Beta (Volatility)

0.38 (Low)

Price

$28.85

Volume

408

Open

$29.24

Previous Close

$28.85

Daily Range

$28.25 - $29.46

52-Week Range

$6.05 - $55.65

NNNN News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Anbio Biotechnology

Industry

Biotechnology

Employees

27

CEO

Michael Lau, PhD, MBA

Headquarters

Frankfurt am Main, 60437, DE

NNNN Financials

Key Financial Metrics (TTM)

Gross Margin

87%

Operating Margin

66%

Net Income Margin

74%

Return on Equity

27%

Return on Capital

21%

Return on Assets

24%

Earnings Yield

0.57%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.25B

Shares Outstanding

43.89M

Volume

408

Short Interest

0.00%

Avg. Volume

56.49K

Financials (TTM)

Gross Profit

$7.54M

Operating Income

$5.77M

EBITDA

$5.77M

Operating Cash Flow

$6.74M

Capital Expenditure

$0.00

Free Cash Flow

$6.74M

Cash & ST Invst.

$11.90M

Total Debt

$0.00

Anbio Biotechnology Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$4.74M

+19.9%

Gross Profit

$3.86M

+128.2%

Gross Margin

81.49%

N/A

Market Cap

$1.25B

N/A

Market Cap/Employee

$46.39M

N/A

Employees

27

N/A

Net Income

$3.04M

+283.2%

EBITDA

$2.80M

+251.5%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$11.90M

+22.8%

Accounts Receivable

$3.66M

+94.0%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

23.76%

N/A

Return on Invested Capital

21.48%

N/A

Free Cash Flow

$1.60M

N/A

Operating Cash Flow

$1.60M

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
AVNSAvanos Medical, Inc.
$24.63+69.51%
KALVKalVista Pharmaceuticals, Inc.
$20.29+3.57%
TALKTalkspace, Inc.
$5.17-0.19%
RIGLRigel Pharmaceuticals, Inc.
$31.39+4.74%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$63.81-0.02%
NOKNokia
$10.35-0.00%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$11.54+0.07%
AALAmerican Airlines Group
$12.13+0.08%

Questions About NNNN

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.